BackElectromed Overview
Electromed Inc.

Electromed Target Price

See Electromed's analyst price targets ($49) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$28

Average Target Price

$48.5073.2% upside

2 analysts in the last 4 months

High: $50 | Low: $47

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-26Morgan Stanley$5078.6% upsideOpen
2026-08-26Lake Street$4767.9% upsideOpen
2026-02-11Roth Capital$3835.7% upsideOpen
2025-08-27Loop Capital MarketsBenjamin Haynor$3628.6% upsideOpen
2025-08-27Roth CapitalKyle Bauser$3525% upsideOpen

Electromed (ELMD) FAQ

Electromed's target price stands at $49. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $49 for ELMD implies 73.2% upside versus today's price ($28.0). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Electromed's target price evolved across reporting periods, while the comparison chart places ELMD next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, target price is commonly used to spot outliers. Electromed's reading of $49 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.